Lisa Wilson | IR |
Scott Tarriff | CEO |
Pete Meyers | CFO |
Mickey Ingerman | Piper Jaffray |
Tim Lugo | William Blair |
Brandon Folkes | Cantor Fitzgerald |
Good day, and welcome to today's program. My name is Leo, and I will be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' Third Quarter 2018 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer period.